


Manager PR & Communications Jan Phillip Denkers

Evotec and APEIRON achieve first milestone in immuno-oncology alliance with Sanofi
Evotec AG and APEIRON Biologics AG, a company focused on cancer immunotherapy, announced today that the companies received the first milestone payment from Sanofi ...
Read more …
The Center for Applied Nanotechnology CAN to become new research division at the Fraunhofer IAP
The Center for Applied Nanotechnology (CAN) GmbH was integrated into the Fraunhofer Institute for Applied Polymer Research (Potsdam-Golm) on January 1, 2018. Under the ...
Read more …
Topas Therapeutics extends its Series A with Boehringer Ingelheim Venture Fund
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, today announced that the Boehringer ...
Read more …
Evotec joins forces with academic leaders to accelerate drug discovery in kidney diseases and build "NEPLEX"
Evotec AG today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell ("iPSC") differentiation with leading academic institutions in the UK ...
Read more …
Topas Therapeutics extends its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, today announced that the Boehringer ...
Read more …
Crystals in a pink X-ray beam
A newly developed experimental set-up allows the X-ray structure determination of biomolecules such as proteins with far smaller samples and shorter exposure times than ...
Read more …
Evotec and Tesaro enter strategic partnership to discover novel immuno-oncology agents
Evotec AG and TESARO, Inc. ("TESARO") today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against ...
Read more …
Call for Entries: Eppendorf Award 2018!
From October 1, 2017, until January 15, 2018, young researchers not older than 35 years, with an advanced degree, who are working in Europe ...
Read more …
Evotec invests in Exscientia to advance AI-driven drug discovery
Evotec AG and Exscientia Ltd ("Exscientia") today announced that Evotec has made a EUR 15 m investment to take a minority stake in Exscientia. ...
Read more …
International X-ray laser European XFEL inaugurated
European XFEL, the largest and most powerful X-ray laser in the world, was officially inaugurated at September 1st in an international event with musical ...
Read more …
Topas Therapeutics signs agreement with Lilly
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private company, today announced that it has signed a multi-year agreement with Eli Lilly and Company (Lilly) ...
Read more …
MedStar Health Collaborates with Indivumed to Advance Precision Oncology Research
MedStar Health will collaborate with Indivumed to advance our understanding of the molecular basis of cancer through collection and analysis of biospecimens and clinical ...
Read more …